OKYO (OKYO Pharma) Interest Expense: $-0.20 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OKYO OKYO Pharma Ltd OKYO
23 GF Score
Price $1.38
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Interest Expense?

OKYO Pharma OKYO -6.76% 23 Interest Expense is $-0.20 Mil as of Sep. 2025. GuruFocus rates OKYO with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OKYO Pharma's interest expense for the six months ended in Sep. 2025 was $ -0.09 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OKYO Pharma's Operating Income for the six months ended in Sep. 2025 was $ -2.50 Mil. OKYO Pharma's Interest Expense for the six months ended in Sep. 2025 was $ -0.09 Mil. OKYO Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OKYO Pharma  (NAS:OKYO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OKYO Pharma's Interest Expense for the six months ended in Sep. 2025 was $-0.09 Mil. Its Operating Income for the six months ended in Sep. 2025 was $-2.50 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2025 was $0.00 Mil.

OKYO Pharma's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

OKYO Pharma did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

OKYO Pharma Interest Expense Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Interest Expense Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 -0.10 -1.05 -0.87

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1.05 -0.76 -0.11 -0.09
OKYO
23GF Score
OKYO Pharma Ltd OKYO
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.20 Mil mean?
OKYO Pharma (OKYO) has a Interest Expense of $-0.20 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on OKYO Pharma and its competitors.
Is OKYO Pharma's Interest Expense too high?
OKYO Pharma's current Interest Expense is $-0.20 Mil. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Interest Expense compare to ENTX and HRTX?
OKYO Pharma's Interest Expense of $-0.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Interest Expense is $-0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Interest Expense of $-0.20 Mil. The current Interest Expense is $-0.20 Mil. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Interest Expense is $-0.20 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for OKYO

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.38
Price